ADAR1 Capital Management »

Solid Biosciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Solid Biosciences (SLDB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Solid Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Solid Biosciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Solid Biosciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.7M 203k 13.32
2023-12-31 $6.1k 1.0k 6.14

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Solid Biosciences

Perceptive Advisors
RA Capital Management
Bain Capital Life Sciences Investors
Vestal Point Capital
Siren
BlackRock
BlackRock
Vanguard Group
Citadel Advisors
Henderson Group
Geode Capital Management
Monashee Investment Management
Silverarc Capital Management
Point72 Asset Management
State Street Corporation

View all funds holding Solid Biosciences